Guadalquiver, Annamae D.
HRN: 18-00-55 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFUROXIME 500MG (TAB)
09/19/2025
09/26/2025
PO
500mg
BID X 7 Days
Thickly MSAF
Checking Initial Appropriateness
09/19/2025
METRONIDAZOLE 500MG (TAB)
09/19/2025
09/26/2025
PO
500mg
TID X 7 Days
Thickly MSAF
Checking Initial Appropriateness